Thursday, 21 March 2013
The Royal College of Pathologists, London, UK
Mycobacterium tuberculosis is one of the most successful human pathogens. Treatment of tuberculosis requires a long duration time with the use of multiple drugs. There is also an alarming emergence of multidrug resistant M. tuberculosis. As a result a need have arisen to develop novel anti-tubercular agents. This EuroSciCon meeting will present cutting-edge research on developments in the detection and treatment of tuberculosis.
Registration Web Site: www.regonline.co.uk/tb2012
